Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
June 2022 Quarterly Activity Report
Browse
Home
ASX Release
June 2022 Quarterly Activity Report
22
Jul
Jul
, 22 ,
2022
Daniel Tillett
June-2022-Quarterly-Activity-Report
Download
Facebook
Tweet
LinkedIn
Related posts:
Zantrene Protects Mouse Hearts from Chemotherapy Damage
Race Receives Human Ethics Approval for Extramedullary AML & MDS Trial
Appointment of Chief Financial Officer
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2022 Race Oncology Ltd